A 2025 study in Biomolecules found that NNMT inhibitor treatment "reduces body weight, white adipose tissue mass, total cholesterol, and adipocyte size in obese mice." These changes suggest cardiovascular benefit beyond simple weight loss
10.1056/NEJMoa2401943 88 Lopez-LeeC.TorresE
The weight loss trajectory at week 37-48 is beginning to decelerate, which is physiologically normal and expected
Interested in Exploring GLP-1 Therapy
After CMS approves the required prior authorization, Susan fills her prescription through the demonstration and pays the programs $50 monthly copayment
Jin J, Liao ZX, Zhang Z, Ajani JA, Swisher SG , Cox JD, Komaki R